{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:20:35Z","timestamp":1790785235917,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Liver transplantation is essential for many people with primary sclerosing cholangitis (PSC). People with PSC are less likely to receive a deceased donor liver transplant compared with other causes of chronic liver disease. This disparity may stem from the inaccuracy of the model for end-stage liver disease (MELD) in predicting waitlist mortality or dropout for PSC. The broad applicability of MELD across many causes comes at the expense of accuracy in prediction for certain causes that involve unique comorbidities. We aimed to develop a model that could more accurately predict dynamic changes in waitlist outcomes among patients with PSC while including complex clinical variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We developed 3 machine learning architectures using data from 4666 patients with PSC in the Scientific Registry of Transplant Recipients (SRTR) and tested our models on our institutional data set of 144 patients at the University Health Network (UHN). We evaluated their time-dependent concordance index (C-index) for mortality prediction and compared it against MELD-sodium and MELD 3.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Random survival forest (RSF), a decision tree\u2013based survival model, outperformed MELD-sodium and MELD 3.0 in both the SRTR and the UHN test data set using the same bloodwork variables and readily available demographic data. It achieved a C-index of 0.868 (SD 0.020) and 0.771 (SD 0.085) on the SRTR and UHN test data, respectively. Training a separate RSF model using the UHN data with PSC-specific achieved a C-index of 0.91. In addition to high MELD score, increased white blood cells, time on the waiting list, platelet count, presence of Autoimmune hepatitis-PSC overlap, aspartate aminotransferase, female sex, age, history of stricture dilation, and extremes of body weight were the top-ranked features predictive of the outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our RSF model offers more accurate waitlist outcome prediction in PSC. The significant performance improvement with the inclusion of PSC-specific variables highlights the importance of disease-specific variables for predicting trajectories of clinically distinct presentations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001774","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T20:23:27Z","timestamp":1743366207000},"page":"e1774","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Machine Learning Prediction Model of Waitlist Outcomes in Patients with Primary Sclerosing Cholangitis"],"prefix":"10.1097","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-7077","authenticated-orcid":false,"given":"Xun","family":"Zhao","sequence":"first","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Naghibzadeh","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingji","family":"Sun","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Rahmani","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lilly","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Selzner","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Tsien","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Pressley","family":"Vyas","sequence":"additional","affiliation":[{"name":"PSC Partners Seeking a Cure Canada, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Computer Science, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Bhat","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"R1-20250328","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population\u2010based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis.","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J Hepatol"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: the model for end-stage liver disease updated for the modern era.","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e31821694b3","article-title":"Current trends in living donor liver transplantation for primary sclerosing cholangitis.","volume":"91","author":"Goldberg","year":"2011","journal-title":"Transplantation"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid.","volume":"3","author":"Satapathy","year":"2017","journal-title":"Transplant Direct"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long\u2010term results of patients undergoing liver transplantation for primary sclerosing cholangitis.","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/lt.26195","article-title":"The impact of primary liver disease and social determinants in a mixed donor liver transplant program: a single\u2010center analysis.","volume":"27","author":"Leung","year":"2021","journal-title":"Liver Transpl"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"e0219","DOI":"10.1097\/HC9.0000000000000219","article-title":"Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis.","volume":"7","author":"Onofrio","year":"2023","journal-title":"Hepatol Commun"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/hep.31103","article-title":"Applying machine learning in liver disease and transplantation: a comprehensive review.","volume":"71","author":"Spann","year":"2020","journal-title":"Hepatology"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2023.01.006","article-title":"Artificial intelligence, machine learning, and deep learning in liver transplantation.","volume":"78","author":"Bhat","year":"2023","journal-title":"J Hepatol"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41746-022-00637-2","article-title":"The promise of machine learning applications in solid organ transplantation.","volume":"5","author":"Gotlieb","year":"2022","journal-title":"NPJ Digital Med"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/jamia\/ocaa088","article-title":"MINIMAR (MINimum Information for Medical AI Reporting): developing reporting standards for artificial intelligence in health care.","volume":"27","author":"Hernandez-Boussard","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0482-1","article-title":"DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network.","volume":"18","author":"Katzman","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees.","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s10620-015-4013-1","article-title":"Factors that influence health-related quality of life in patients with primary sclerosing cholangitis.","volume":"61","author":"Cheung","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cgh.2018.09.046","article-title":"Increased mortality among patients with vs without cirrhosis and autoimmune hepatitis.","volume":"17","author":"van den Brand","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.TP.0000101009.91516.FC","article-title":"Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1.","volume":"77","author":"Desai","year":"2004","journal-title":"Transplantation"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jlts.2003.50122","article-title":"Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients.","volume":"9","author":"Hayashi","year":"2003","journal-title":"Liver Transpl"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis.","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"R27-20250328","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study.","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R28-20250328","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","article-title":"A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.","volume":"67","author":"de Vries","year":"2018","journal-title":"Gut"},{"key":"R29-20250328","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system.","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"R30-20250328","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.30085","article-title":"Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning.","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"key":"R31-20250328","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long\u2010term outcome and survival.","volume":"28","author":"Al\u2010Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-20250328","doi-asserted-by":"crossref","first-page":"e23556","DOI":"10.1002\/jcla.23556","article-title":"Platelet\u2010to\u2010white blood cell ratio: a novel and promising prognostic marker for HBV\u2010associated decompensated cirrhosis.","volume":"34","author":"Zhang","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"R33-20250328","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.3390\/jcm11092463","article-title":"Platelet-to-white blood cell ratio is associated with adverse outcomes in cirrhotic patients with acute deterioration.","volume":"11","author":"Kim","year":"2022","journal-title":"J Clin Med"},{"key":"R34-20250328","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/lt.23587","article-title":"Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis.","volume":"19","author":"Goldberg","year":"2013","journal-title":"Liver Transpl"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T20:24:17Z","timestamp":1743366257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001774","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}